Clinical Trial: A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749703) titled 'A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors' on Aug. 03.

Brief Summary: an open-label, multicenter, Phase I study designed to evaluate the safety, tolerability, efficacy, and pharmacokinetic/pharmacodynamic (PK/PD) characteristics of SIM0532 in participants with advanced solid tumors. The

study commences with a dose-escalation part (Part 1), followed by a dose-expansion part (Part 2).

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Histologically or Cytologically Confirmed Advanced Solid Tumors

Intervention: DRUG: SIM0532 Tablets

SIM0532 Tablets

Recruitment Status: ACTIVE_NOT_...